Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes

Cunha, João Paulo M C M LU orcid ; Leuckx, Gunter ; Sterkendries, Peter ; Korf, Hannelie ; Bomfim-Ferreira, Gabriela ; Overbergh, Lutgart ; Vaes, Bart ; Heimberg, Harry ; Gysemans, Conny and Mathieu, Chantal (2017) In Diabetologia 60(1). p.134-142
Abstract

AIMS/HYPOTHESIS: Hypoxia in the initial days after islet transplantation leads to considerable loss of islet mass and contributes to disappointing outcomes in the clinical setting. The aim of the present study was to investigate whether co-transplantation of human non-endothelial bone marrow-derived multipotent adult progenitor cells (MAPCs), which are non-immunogenic and can secrete angiogenic growth factors during the initial days after implantation, could improve islet engraftment and survival.

METHODS: Islets (150) were co-transplanted, with or without human MAPCs (2.5 × 105) as separate or composite pellets, under the kidney capsule of syngeneic alloxan-induced diabetic C57BL/6 mice. Blood glucose levels were frequently... (More)

AIMS/HYPOTHESIS: Hypoxia in the initial days after islet transplantation leads to considerable loss of islet mass and contributes to disappointing outcomes in the clinical setting. The aim of the present study was to investigate whether co-transplantation of human non-endothelial bone marrow-derived multipotent adult progenitor cells (MAPCs), which are non-immunogenic and can secrete angiogenic growth factors during the initial days after implantation, could improve islet engraftment and survival.

METHODS: Islets (150) were co-transplanted, with or without human MAPCs (2.5 × 105) as separate or composite pellets, under the kidney capsule of syngeneic alloxan-induced diabetic C57BL/6 mice. Blood glucose levels were frequently monitored and IPGTTs were carried out. Grafts and serum were harvested at 2 and 5 weeks after transplantation to assess outcome.

RESULTS: Human MAPCs produced high amounts of angiogenic growth factors, including vascular endothelial growth factor, in vitro and in vivo, as demonstrated by the induction of neo-angiogenesis in the chorioallantoic membrane assay. Islet-human MAPC co-transplantation as a composite pellet significantly improved the outcome of islet transplantation as measured by the initial glycaemic control, diabetes reversal rate, glucose tolerance and serum C-peptide concentration compared with the outcome following transplantation of islets alone. Histologically, a higher blood vessel area and density in addition to a higher vessel/islet ratio were detected in recipients of islet-human MAPC composites.

CONCLUSIONS/INTERPRETATION: The present data suggest that co-transplantation of mouse pancreatic islets with human MAPCs, which secrete high amounts of angiogenic growth factors, enhance islet graft revascularisation and subsequently improve islet graft function.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Adult, Animals, Blood Glucose/physiology, Cells, Cultured, Diabetes Mellitus, Experimental/physiopathology, Diabetes Mellitus, Type 1/physiopathology, Disease Models, Animal, Female, Humans, Islets of Langerhans/metabolism, Male, Mice, Inbred C57BL, Middle Aged, Neovascularization, Physiologic/physiology, Stem Cell Transplantation/methods, Stem Cells/cytology
in
Diabetologia
volume
60
issue
1
pages
9 pages
publisher
Springer
external identifiers
  • pmid:27704164
  • scopus:84990857109
ISSN
1432-0428
DOI
10.1007/s00125-016-4120-3
language
English
LU publication?
no
id
5cc2cc0f-df2d-49c9-b907-1ca114c09ecf
date added to LUP
2019-02-14 09:29:39
date last changed
2024-04-30 01:11:11
@article{5cc2cc0f-df2d-49c9-b907-1ca114c09ecf,
  abstract     = {{<p>AIMS/HYPOTHESIS: Hypoxia in the initial days after islet transplantation leads to considerable loss of islet mass and contributes to disappointing outcomes in the clinical setting. The aim of the present study was to investigate whether co-transplantation of human non-endothelial bone marrow-derived multipotent adult progenitor cells (MAPCs), which are non-immunogenic and can secrete angiogenic growth factors during the initial days after implantation, could improve islet engraftment and survival.</p><p>METHODS: Islets (150) were co-transplanted, with or without human MAPCs (2.5 × 105) as separate or composite pellets, under the kidney capsule of syngeneic alloxan-induced diabetic C57BL/6 mice. Blood glucose levels were frequently monitored and IPGTTs were carried out. Grafts and serum were harvested at 2 and 5 weeks after transplantation to assess outcome.</p><p>RESULTS: Human MAPCs produced high amounts of angiogenic growth factors, including vascular endothelial growth factor, in vitro and in vivo, as demonstrated by the induction of neo-angiogenesis in the chorioallantoic membrane assay. Islet-human MAPC co-transplantation as a composite pellet significantly improved the outcome of islet transplantation as measured by the initial glycaemic control, diabetes reversal rate, glucose tolerance and serum C-peptide concentration compared with the outcome following transplantation of islets alone. Histologically, a higher blood vessel area and density in addition to a higher vessel/islet ratio were detected in recipients of islet-human MAPC composites.</p><p>CONCLUSIONS/INTERPRETATION: The present data suggest that co-transplantation of mouse pancreatic islets with human MAPCs, which secrete high amounts of angiogenic growth factors, enhance islet graft revascularisation and subsequently improve islet graft function.</p>}},
  author       = {{Cunha, João Paulo M C M and Leuckx, Gunter and Sterkendries, Peter and Korf, Hannelie and Bomfim-Ferreira, Gabriela and Overbergh, Lutgart and Vaes, Bart and Heimberg, Harry and Gysemans, Conny and Mathieu, Chantal}},
  issn         = {{1432-0428}},
  keywords     = {{Adult; Animals; Blood Glucose/physiology; Cells, Cultured; Diabetes Mellitus, Experimental/physiopathology; Diabetes Mellitus, Type 1/physiopathology; Disease Models, Animal; Female; Humans; Islets of Langerhans/metabolism; Male; Mice, Inbred C57BL; Middle Aged; Neovascularization, Physiologic/physiology; Stem Cell Transplantation/methods; Stem Cells/cytology}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{134--142}},
  publisher    = {{Springer}},
  series       = {{Diabetologia}},
  title        = {{Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes}},
  url          = {{http://dx.doi.org/10.1007/s00125-016-4120-3}},
  doi          = {{10.1007/s00125-016-4120-3}},
  volume       = {{60}},
  year         = {{2017}},
}